Advancing toxicology in RiskMAPP: setting ADEs based on the subsequent drug substance.

Bercu, Joel P; Sharnez, Rizwan; Dolan, David G

Bercu, Joel P; Sharnez, Rizwan; Dolan, David G.

Affiliation

Bercu JP; Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA. jbercu@amgen.com

Regul Toxicol Pharmacol ; 65(1): 157-61, 2013 Feb.

Article in En | MEDLINE | ID: mdl-22921793

Subject(s)

Drug Contamination/prevention & control; Drug Industry/standards; Pharmaceutical Preparations/standards; Animals; Drug Industry/instrumentation; Drug Industry/methods; Drug-Related Side Effects and Adverse Reactions; Equipment Contamination/prevention & control; Humans; International Agencies; Pharmaceutical Preparations/administration & dosage; Risk Assessment/methods; Toxicology/methods

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pharmaceutical Preparations / Drug Contamination / Drug Industry Type of study: Etiology_studies / Risk_factors_studies Limits: Animals / Humans Language: En Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google